United States - English - NLM (National Library of Medicine)

energique, inc. - zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds) - zinc 200 [hp_c] in 1 ml - to be used according to standard homeopathic indications.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

d3 development, inc. - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 2 g in 100 ml - purposes dandruff, seborrheic dermatitis uses controls, reduces, and helps stop the symptoms of dandruff and seborrheic dermatitis. stop use and ask a doctor if condition worsens or does not improve after regular use as directed.

United States - English - NLM (National Library of Medicine)

chain drug manufacturing assn - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - zinc gluconate 1 [hp_x]

United States - English - NLM (National Library of Medicine)

energique, inc. - zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds) - may temporarily relieve nervous system imbalances such as exhaustion and restless legs** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve nervous system imbalances such as exhaustion and restless legs** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37) - zinc sulfate injection is indicated in adult and pediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. zinc sulfate injection is contraindicated in patients with known hypersensitivity to zinc [see warnings and precautions (5.6)] risk summary administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with intravenous zinc sulfate.  the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown.  all pregnancies have a background risk of birth defect, loss, or other adverse outcomes.  in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. clinical considerations disease-associated maternal and/or embryo-fetal risk deficiency of trace elements, including zinc, is associated with adverse pregnancy and fetal outcomes. pregnant women have an increased metabolic demand for trace elements, including zinc.  parenteral nutrition with zinc should be considered if a pregnant woman’s nutritional requirements cannot be fulfilled by oral or enteral intake. risk summary zinc is present in human milk. administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause harm to a breastfed infant. there is no information on the effects of zinc sulfate on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for zinc sulfate injection and any potential adverse effects on the breastfed infant from zinc sulfate injection or from the underlying maternal condition. zinc sulfate injection is approved for use in the pediatric population, including neonates, as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. safety and dosing recommendations in pediatric patients are based on published literature describing controlled studies of zinc-containing products in pediatric patients [see dosage and administration (2.2)] . because of immature renal function, preterm infants receiving prolonged parenteral nutrition treatment with zinc sulfate injection may be at higher risk of aluminum toxicity [see warnings and precautions (5.3)] . reported clinical experience with intravenous zinc sulfate has not identified a difference in zinc requirements between elderly and younger patients.  in general, dose selection should be individualized based on the patient’s clinical condition, nutritional requirements, and additional nutritional intake provided orally or enterally to the patient.

United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 200 mg in 1 g - skin protectant uses:

United States - English - NLM (National Library of Medicine)

izeen pharma, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37), zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - zinc cation 2 [hp_x] - reduces duration and severity of the common cold - reduces duration of the common cold - reduces the severity of cold symptoms: sore throat stuffy nose sneezing coughing nasal congestion - sore throat - stuffy nose - sneezing - coughing - nasal congestion zicam® ultra cold remedy was formulated to shorten the duration of the common cold and was not formulated to be effective for flu or allergies.

United States - English - NLM (National Library of Medicine)

matrixx initiatives, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37), zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - zinc cation 2 [hp_x] - reduces duration and severity of the common cold - reduces duration of the common cold - reduces severity of cold symptoms: sore throat stuffy nose sneezing coughing nasal congestion - sore throat - stuffy nose - sneezing - coughing - nasal congestion zicam® ultra cold remedy was formulated to shorten the duration of the common cold and was not formulated to be effective for flu or allergies.

United States - English - NLM (National Library of Medicine)

izeen pharma, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37), zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - reduces duration and severity of the common cold -  may reduce duration of the common cold -  may reduce the severity of cold symptoms stuffy nose sneezing coughing nasal congestion - stuffy nose - sneezing - coughing - nasal congestion

United States - English - NLM (National Library of Medicine)

chain drug marketing association inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - skin protectant - protects skin - protects and releives chafed skin due to diaper rash - helps seal out wetness - dries the oozing and weeping of poison ivy, oak and sumac